Zinzino group revenue increased 18 % in Q3, compared with the previous year. GOTHENBURG, Sweden, Oct. 5, 2026 /PRNewswire/ -- The revenue in September for Zinzino's sales markets increased by 15% and amounted to SEK 310.9 (270.8) million. Faun Pharma's external sales increased and...
NEEDHAM, Mass., Oct 5, 2026 /PRNewswire/ -- Evident announced today that it has completed the acquisition of CrestOptics S.p.A., a Rome-based developer and manufacturer of advanced optical imaging systems for spinning disk confocal and super-resolution microscopy. The acquisition broadens...
NEEDHAM, Massachusetts, 5 octobre 2026 /PRNewswire/ -- Evident annonce aujourd'hui avoir finalisé l'acquisition de CrestOptics S.p.A., une société basée à Rome spécialisée dans le développement et la fabrication de systèmes d'imagerie optique de pointe destinés à la microscopie confocale...
NEEDHAM, Massachusetts, 5. Oktober 2026 /PRNewswire/ -- Evident verkündete heute, dass es die Übernahme von CrestOptics S.p.A. abgeschlossen hat, einem in Rom ansässigen Entwickler und Hersteller fortschrittlicher optischer Bildgebungssysteme für die Spinning-Disk-Konfokalmikroskopie und...
STOCKHOLM, Oct. 5, 2026 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) today announcedthe publication of new analyses demonstrating potent antifungal activity of terbinafine against dermatophytes causing onychomycosis. Importantly, mycological cure with MOB-015 was achieved across the full...
Una nueva investigación europea revela que el 81 % reconoce la importancia de proteger la piel más allá de los rayos UV; sin embargo, solo el 22 % utiliza productos destinados a reforzar la barrera cutánea. VIENA, 5 de octubre de 2026 /PRNewswire/ -- CeraVe, la marca de cuidado de la piel...
Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care AUCKLAND, New Zealand, Oct. 5, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a...
The only known investigational therapy for SBMA in Phase 3 development worldwide AJ201 (rosolutamide) is an investigational oral small molecule designed to address multiple disease mechanisms of spinal and bulbar muscular atrophy (SBMA, or Kennedy's disease) Following submission of the...
MAILAND, 5. Oktober 2026 /PRNewswire/ -- Auf der Tagung der Europäischen Vereinigung für Diabetesforschung (EASD) 2026 präsentierte SiBionics unter dem Motto „See More, Act Earlier" die Verknüpfung von kontinuierlicher Messtechnik mit der Diabetesversorgung der Zukunft. Diese Vision wurde...
HAMILTON, ON, Oct. 4, 2026 /PRNewswire/ -- Latitude Air Ambulance today issued the following statement regarding Heartbeat 104 Medevac, which was operating from Bermuda to Boston, Massachusetts: It is with profound sadness that we acknowledge the decision by the United States Coast Guard...